Kim Lorence H. — SEC Form 4 filings
SEC reporting owner CIK 1643746. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-13 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 2 filings — 73,090 shares, $14,967,125 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 26,160 shares @ $203.55 ($5,324,824) in Revolution Medicines, Inc., filed 2026-09-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Director | 6 | — | 14 legs · 73,090 sh · $14,967,125 | 8 |
| Cencora, Inc. (COR) | Director | 3 | — | — | 3 |
Form 4 filings — Kim Lorence H.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 706 @ $206.60 · Sale (S): 999 @ $207.33 · Sale (S): 3,587 @ $208.55 · Sale (S): 2,853 @ $209.56 · Sale (S): 4,730 @ $210.50 · Sale (S): 3,844 @ $211.36 · +1 more | EDGAR |
| 2026-09-02 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 300 @ $200.56 · Sale (S): 6,597 @ $201.47 · Sale (S): 12,919 @ $202.48 · Sale (S): 26,160 @ $203.55 · Sale (S): 7,271 @ $204.35 · Sale (S): 2,128 @ $205.19 · +1 more | EDGAR |
| 2026-06-23 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Cencora, Inc. (COR) | Grant/award (A): 557 @ $359.28 | EDGAR |
| 2025-06-30 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 3,142 @ $0 · Grant/award (A): 11,574 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Cencora, Inc. (COR) | Grant/award (A): 789 | EDGAR |
| 2024-06-28 | 4/A | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 4,248 @ $0 · Grant/award (A): 15,955 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 4,800 @ $0 · Grant/award (A): 16,700 (derivative) @ $0 | EDGAR |
| 2024-03-13 | 4 | Cencora, Inc. (COR) | Grant/award (A): 843 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1643746 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →